Symbol
| CDH11
| contributors: mct - updated : 27-08-2015
|
HGNC name
| cadherin 11, type 2, OB-cadherin (osteoblast)
|
HGNC id
| 1750
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| LOH
|  
|  
|
in retinoblastoma | tumoral
|  
|  
| --low
|  
|
in breast cancer, correlated with a loss of the epithelial phenotype and with a gain of invasiveness | constitutional
|  
|  
| --other
|  
|
down-modulation by potent antiinflammatory therapies in humans with arthritis may contribute to halting cartilage damage ( | tumoral
|  
|  
| --over
|  
|
expression increasing from primary to metastatic disease in lymph nodes and especially bone | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
immunology | autoimmune | articular | |
useful therapeutic target for inflammatory arthritis |
| | | |
| cadherin-11-deficient mice have a hypoplastic synovial lining, display a disorganized synovial reaction to inflammation, and are resistant to inflammatory arthritis |